Artificial intelligence technologies empowering identification of novel diagnostic molecular markers in gastric cancer
In recent clinical practice the molecular diagnostics have been significantly empowered and upgraded by the use of Artificial Intelligence and its assisted technologies. The use of Machine leaning and Deep Learning Neural network architectures have brought in a new dimension in clinical oncological...
Guardado en:
Autores principales: | Ishan Pandey, Vatsala Misra, Aprajita T Pandey, Pramod W Ramteke, Ranjan Agrawal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90ae1ff6dc674db1b6baca514e70c98f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expresión y amplificación del gen HER2 en el cáncer gástrico avanzado
por: Roa,Iván, et al.
Publicado: (2013) -
Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
por: Prasenjit Das, et al.
Publicado: (2021) -
Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
por: Kotzev A., et al.
Publicado: (2017) -
Intraoral Mucoepidermoid Carcinoma of Salivary Glands: Lack of Association Among Clinicopathological Features and Immunoexpression of c-erbB-2 in 29 Cases
por: Bernardes,Vanessa Fátima, et al.
Publicado: (2008) -
Cáncer de metaplásico de mama: revisión de dos casos clínicos
por: Ortega Marcilla,S., et al.
Publicado: (2018)